Recent Press Releases

Scientists at Japan's Kyushu University say polymer-wrapped carbon nanotubes hold much promise in biotechnology and energy applications

Tsukuba, Japan, - (ACN Newswire) - Scientists first reported carbon nanotubes in the early 1990s. Since then, these tiny cylinders have been part of the quest to reduce the size of technological...

Catch-release-repeat: Study reveals novel technique for handling molecules

Like vast international trading companies, biological systems pick up freight items (in the form of small molecules), transport them from place to place and release them at their proper destination....

Rigontec GmbH Raises €4.8m in a Second Closing of its Series A Financing

BONN, Germany, March 24, 2015 /PRNewswire via COMTEX/ -- BONN, Germany, March 24, 2015 /PRNewswire/ -- Brings Series A total to €14.25m to advance RNA-based immunotherapeutics for cancer and...

Special microbes make anti-obesity molecule in the gut

DENVER, March 22, 2015 -- Microbes may just be the next diet craze. Researchers have programmed bacteria to generate a molecule that, through normal metabolism, becomes a hunger-suppressing lipid....

ISA Scientific, Yissum, Hadasit and the Kennedy Trust for Rheumatology Research to Collaborate on Treating Diabetes and Other Serious Health Conditions with Cannabidiol

March 23, 2015 08:00 AM Eastern Daylight Time JERUSALEM--()--Yissum Research Development Company Ltd. (Yissum), the technology transfer company of the Hebrew University of Jerusalem,...

Takeda Licenses Rights to Use ImmunoGen, Inc.'s Novel Antibody-Drug Conjugate Technology

March 23, 2015 06:30 AM Eastern Daylight Time CAMBRIDGE & WALTHAM, Mass.--()--Takeda Pharmaceutical Company Limited (TSE:4502) and ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology...

MHB Labs Completes $1.1M Seed Financing Round for Physician Driven Product Development

MHB Labs has raised over $1.1M from Romulus Capital and a group of angel investors including prominent physicians and biotechnology entrepreneurs to support early stage development of men's...

Clearside Biomedical, Inc. Reports Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide

Patients Treated in the Clinical Trial Exhibited Improvement in Best Corrected Visual Acuity No Meaningful Increases in IOP Observed; No Patient Required IOP-lowering Medication ALPHARETTA,...

Biodel's Glucagon Formulation for Use in a Proprietary Auto-Reconstitution Device for the Treatment of Severe Hypoglycemia Meets Primary Efficacy Endpoint in Phase 1 Clinical Trial

BIOD-961 Administration Results in Glucagon Exposure and Glucose Response That Meets Standard Bioequivalence Criteria When Compared to Marketed Glucagon; Conference Call and Webcast Will be Held on...

Glide Announces Successful Results from Skin Delivery and Human Factor Studies with Novel Solid Dose Injection System

OXFORD, England, March 16, 2015 /PRNewswire/ -- Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today...

Depomed Secures $575 Million Debt Facility From Deerfield and Pharmakon to Finance the Closing of NUCYNTA® Acquisition

NEWARK, Calif., March 12, 2015 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to borrow $575...

Actavis Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder

First atypical antipsychotic to be approved for pediatric patients with bipolar I disorder in the last five years Important additional treatment option for children and teens DUBLIN, March 13,...

Halozyme Therapeutics Reports Selection Of First Product Candidate Under Janssen Collaboration

SAN DIEGO, March 10, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported today that Genmab A/S announced plans for a Phase 1 clinical trial of a subcutaneous formulation of the...

DARA BioSciences Announces the Acquisition of Exclusive North American Rights to Oravig(R) (Miconazole Buccal Tablets 50mg), From Onxeo S.A.

DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care specialty pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer...

Pacira Receives Complete Response Letter from FDA for sNDA Seeking Approval of EXPAREL® Use in Nerve Block to Provide Postsurgical Analgesia

PARSIPPANY, N.J.-- Pacira Pharmaceuticals, Inc.(NASDAQ: PCRX) today announced the receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following a review of...

Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology

Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology HAYWARD, Calif., March 3, 2015 /PRNewswire/ -- Chrono Therapeutics, a pioneer in digital...

Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit

Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy March 02, 2015: 04:01 PM ET THOUSAND OAKS,...

Follicept™ Hair Growth Gel Set for Launch in 2015 by UF Transdermal Delivery Startup

February 24, 2015 08:30 AM Eastern Standard Time GAINESVILLE, Fla.--()--With the patent expiration of Rogaine® and Propecia®, there is no longer a clear market leader in the...

Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc.

23rd February 2015 16:30 Business Wire India Ferring Pharmaceuticals announced today that it has signed an agreement with CTCBIO Inc. of Seoul, South Korea to acquire rights to a novel oral drug...

WHO calls for worldwide use of "smart" syringes

23 FEBRUARY 2015 | GENEVA - Use of the same syringe or needle to give injections to more than one person is driving the spread of a number of deadly infectious diseases worldwide. Millions of people...